JUNALOX naloxone hydrochloride (as dihydrate) 400 micrograms/1 mL solution for injection, ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

junalox naloxone hydrochloride (as dihydrate) 400 micrograms/1 ml solution for injection, ampoule

juno pharmaceuticals pty ltd - naloxone hydrochloride dihydrate, quantity: 440 microgram/ml (equivalent: naloxone hydrochloride?, qty 400 microgram/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid - junalox is indicated for the treatment of opioid overdose.

NALOXONE JUNO NEONATAL naloxone hydrochloride (as dihydrate) 40 micrograms/2 mL solution for injection, ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

naloxone juno neonatal naloxone hydrochloride (as dihydrate) 40 micrograms/2 ml solution for injection, ampoule

juno pharmaceuticals pty ltd - naloxone hydrochloride dihydrate, quantity: 22 microgram/ml (equivalent: naloxone hydrochloride?, qty 20 microgram/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid - naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by opioids including natural and synthetic opioids, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol. naloxone hydrochloride injection is also indicated for the diagnosis of suspected acute opioid overdosage.

BRIMICA GENUAIR 340/12 aclidinium bromide and formoterol fumarate dihydrate powder for inhalation dry powder inhaler Australia - English - Department of Health (Therapeutic Goods Administration)

brimica genuair 340/12 aclidinium bromide and formoterol fumarate dihydrate powder for inhalation dry powder inhaler

a menarini australia pty ltd - aclidinium bromide, quantity: 0.4 mg/actuation; formoterol fumarate dihydrate, quantity: 0.012 mg/actuation - inhalation, powder for - excipient ingredients: lactose monohydrate - brimica genuair 340/12 is indicated as a long-term twice daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).